Biogen Idec, Inc. (Massachusetts) 1st-Quarter Earnings Up But Sales Disappoint

BOSTON, April 16 (Reuters) - Biogen Idec Inc said on Thursday its first-quarter earnings rose but overall revenue and sales of its main drugs fell short of market expectations.
MORE ON THIS TOPIC